Agenus Inc. (AGEN) is primed for evolution with the beta value of 1.27 – Invest Chronicle

Agenus Inc. (AGEN) is primed for evolution with the beta value of 1.27

Let’s start up with the current stock price of Agenus Inc. (AGEN), which is $1.80 to be very precise. The Stock rose vividly during the last session to $1.86 after opening rate of $1.63 while the lowest price it went was recorded $1.62 before closing at $1.65.Recently in News on June 21, 2022, Agenus to Host Investor Webcast to Review Late-Breaking Botensilimab and Balstilimab Data Presented at ESMO World GI Congress. Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced the Company will host a hybrid webcast to discuss botensilimab/balstilimab combination data in microsatellite stable colorectal cancer (MSS-CRC) presented earlier that day in a late-breaking oral presentation at the ESMO World Congress on Gastrointestinal Cancer in Barcelona, Spain. You can read further details here

Agenus Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.4900 on 01/04/22, with the lowest value was $1.2500 for the same time period, recorded on 06/14/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Agenus Inc. (AGEN) full year performance was -65.25%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Agenus Inc. shares are logging -73.49% during the 52-week period from high price, and 44.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.25 and $6.79.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4855891 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Agenus Inc. (AGEN) recorded performance in the market was -44.10%, having the revenues showcasing -35.48% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 433.84M, as it employees total of 441 workers.

Analysts verdict on Agenus Inc. (AGEN)

During the last month, 0 analysts gave the Agenus Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 2.2146, with a change in the price was noted -0.69. In a similar fashion, Agenus Inc. posted a movement of -27.71% for the period of last 100 days, recording 4,371,114 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AGEN is recording 0.90 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Agenus Inc. (AGEN): Technical Analysis

Raw Stochastic average of Agenus Inc. in the period of last 50 days is set at 45.45%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 90.16%. In the last 20 days, the company’s Stochastic %K was 75.34% and its Stochastic %D was recorded 63.48%.

Let’s take a glance in the erstwhile performances of Agenus Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -44.10%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -49.01%, alongside a downfall of -65.25% for the period of the last 12 months. The shares increased approximately by 38.46% in the 7-day charts and went up by 14.65% in the period of the last 30 days. Common stock shares were lifted by -35.48% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts